Home > Insider Trading > Filing (0001213900-18-002972)

Filing Details

Accession Number:: 0001213900-18-002972
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-14 16:30:39
Reporting Period:: 2018-03-13

Accepted Time:: 2018-03-14 16:30:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
707511	Regenerx Biopharmaceuticals Inc	RGRX	Pharmaceutical Preparations (2834)	521253406

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1092601	Spa Essetifin	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1163608	Paolo Cavazza	Via Tesserete, 10 Lugano V8 00000	No	No	Yes	No
1525742	Francesca Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1525743	Silvia Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1525744	Enrico Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1718557	Martina Preta Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-13	11,584,795	$0.23	25,506,521	No	4	P	Direct
Common Stock	Acquisiton	2018-03-13	6,348,878	$0.23	31,855,399	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Note (right to buy)	Acquisiton	2018-03-13	0	$150,000.00	0	$0.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,500,000	2013-09-12		No	4	P	Direct

Footnotes

Represents shares sold by Sinaf S.A., a Luxembourg corporation ("Sinaf"), and purchased by Essetifin S.p.A., an Italian corporation ("Essetifin"), pursuant to a purchase agreement by and between Sinaf and Essetifin (the "Sinaf Agreement").
Represents shares sold by Taufin International S.A., a Luxembourg corporation ("Taufin"), and purchased by Essetifin, pursuant to a purchase agreement by and between Taufin and Essetifin.
Represents a $150,000 convertible promissory note (the "Note") sold by Sinaf and purchased by Essetifin for an aggregate of $183,780.82, pursuant to the Sinaf Agreement. The reporting person purchased the Note on September 12, 2013, from the issuer in a private placement. The Note and any accrued interest thereon are convertible at the option of the holder at any time prior to repayment of the Note into common stock at a conversion price of $0.06 per share. The Note is payable upon the written demand of the holder thereof at any time after September 10, 2018 (the "Maturity Date"). Interest accrues on the unpaid principal amount at a rate equal to 5% per annum, but it is not due and payable until the written demand of the holder for payment on or after the Maturity Date. The current outstanding principal amount, if converted into common stock, would result in the issuance of 2,500,000 shares. The number of shares of common stock to be issued upon conversion will be fixed on the conversion date.
Does not include shares issuable at the election of the reporting person upon conversion of accrued interest into shares of common stock.
Paolo Cavazza previously reported indirect ownership of such securities due to his ownership interest in Sinaf, which is a directly wholly-owned subsidiary of Aptafin S.p.A., which is owned indirectly by Paolo Cavazza and members of his family. Paolo Cavazza continues to have an indirect interest in such shares through his ownership interest in Essetifin.
Dispositive power over the shares of common stock owned by Essetifin is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin except to the extent of any pecuniary interest therein.